Medtronic MiniMed™ 780G Advanced Hybrid Closed Loop System
Medtronic has secured a CE (Conformité Européenne) Mark for MiniMed™ 780G Advanced Hybrid Closed Loop System. The next generation closed loop insulin pump system features auto-correction algorithm and bluetooth connectivity, designed to further simplify Type 1 diabetes management
The system automates the delivery of both basal insulin and correction boluses every five minutes to help people with diabetes avoid highs and lows with greater ease. The MiniMed 780G system enables the personalization of glucose goals with an adjustable target setting as low as 100 mg/dL (5.5 mmol/L) — lower than any other advanced hybrid closed loop system — and is designed to help stabilize blood sugar levels and further improve glucose control.
In addition to the automated algorithm which includes technology from DreaMed Diabetes, the MiniMed 780G system was designed to be easy to use by requiring less input from the user1. With the addition of Bluetooth connectivity, the MiniMed 780G system will enable users and their care partners to see real-time glucose data and trends on compatible iOS and Android smartphones via apps.
The system is expected to begin shipping later this year in select countries in the EU.
